Pfizer COVID-19 vaccine safe, effective in cancer patients, despite 'lagging' response, study says
The two-dose Pfizer-BioNTech COVID-19 vaccine provides an effective immune response and is safe in people undergoing treatment for certain types of cancer, a study published Thursday by JAMA Oncology found.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | COVID-19 | Health | Pfizer | Study | Vaccines